Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

Thiosulfate enhances the activity of rhodanese by donating a sulfur group, thereby increasing the amount of thiocyanate that rhodanese can produce. [52] Sodium thiosulfate is relatively well ...

[21] In our experience, patch-test results were negative at day = but became positive by day 7 or later for the following metals: gold sodium thiosulfate 0.5%, palladium chloride 2%, potassium ...

Announced that Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, has commercially launched PEDMARQSI (sodium thiosulfate injection) in Germany. Fennec Pharmaceuticals ...

This requires a conical flask and gas syringe. Sodium thiosulfate reacts with dilute hydrochloric acid to produce sodium chloride, water, sulfur dioxide and sulfur. The sulfur makes the solution ...